Literature DB >> 2384743

Partial purification and characterization of a soluble protein kinase from Leishmania donovani promastigotes.

C Banerjee1, D Sarkar.   

Abstract

A soluble protein kinase from the promastigote form of the parasitic protozoon Leishmania donovani was partially purified using DEAE-cellulose, Sephadex G-200 and phosphocellulose columns. The enzyme preferentially utilized protamine as exogenous phosphate acceptor. The native molecular mass of the enzyme was about 85 kDa. Mg2+ ions were essential for enzyme activity; other metal ions, e.g. Ca2+, Co2+, Zn2+ and Mn2+, could not substitute for Mg2+. cAMP, cGMP, Ca2+/calmodulin and Ca2+/phospholipid did not stimulate enzyme activity. The pH optimum of the enzyme was 7.0-7.5, and the temperature optimum 37 degrees C. The apparent Km for ATP was 60 microM. Phosphoamino acid analysis revealed that the protein kinase transferred the gamma-phosphate of ATP to serine residues in protamine. The thiol reagents p-hydroxymercuribenzoic acid, 5-5'-dithio-bis(2-nitrobenzoic acid) and N-ethylmaleimide inhibited enzyme activity; the inhibition by p-hydroxymercuribenzoic acid and 5-5'-dithio-bis(2-nitrobenzoic acid) was reversed by dithiothreitol.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384743     DOI: 10.1099/00221287-136-6-1051

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  3 in total

1.  Partial purification and characterization of a soluble protein phosphatase from Leishmania donovani promastigotes.

Authors:  S Nandi; D Sarkar
Journal:  Mol Cell Biochem       Date:  1995-07-19       Impact factor: 3.396

2.  Role of cyclic adenosine monophosphate in phospholipid synthesis in Mycobacterium smegmatis ATCC 607.

Authors:  H Kaur; G K Khuller
Journal:  Lipids       Date:  1995-04       Impact factor: 1.880

3.  Infectivity of Leishmania mexicana is associated with differential expression of protein kinase C-like triggered during a cell-cell contact.

Authors:  Nidia Alvarez-Rueda; Marlène Biron; Patrice Le Pape
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.